MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer

The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. The identification of predictive moleculobiological markers allowing risk assessment of lymph node metastasis and systemic progression is essential in establishing effective treatment. In the current st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalogirou, Charis, Spahn, Martin, Krebs, Markus, Joniau, Steven, Lerut, Evelyne, Burger, Maximilian, Scholz, Claus-Jürgen, Kneitz, Susanne, Riedmiller, Hubertus, Kneitz, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856012/
https://www.ncbi.nlm.nih.gov/pubmed/24173237
http://dx.doi.org/10.3390/ijms141121414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856012/
https://www.ncbi.nlm.nih.gov/pubmed/24173237
http://dx.doi.org/10.3390/ijms141121414

Ejemplares similares